114 related articles for article (PubMed ID: 9223653)
1. Pharmacophore requirements in new series of pyridazinyl alkanoic acids, N-[(pyridazin-2-yl) alkyl] succinyl and glutaryl amides, inhibitors of thromboxane A2 biosynthesis.
Moreau S; Coudert P; Lasserre B; Vallée-Goyet D; Gardette D; Navarro-Delmasure C; Pham Huu Chanh A; Dossou-Gbete V; Couquelet J
Prostaglandins Leukot Essent Fatty Acids; 1997 Jun; 56(6):431-6. PubMed ID: 9223653
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane A2 biosynthesis inhibitors: synthesis and evaluation of pyrazolotriazinyl alkanoic acids.
Lasserre B; Mavel S; Coudert P; Pham Huu Chanh A; Navarro-Delmasure C; Dossou-Gbete V; Couquelet J
Prostaglandins Leukot Essent Fatty Acids; 1994 Sep; 51(3):157-61. PubMed ID: 7824529
[TBL] [Abstract][Full Text] [Related]
3. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids.
Cozzi P; Giordani A; Menichincheri M; Pillan A; Pinciroli V; Rossi A; Tonani R; Volpi D; Tamburin M; Ferrario R
J Med Chem; 1994 Oct; 37(21):3588-604. PubMed ID: 7932586
[TBL] [Abstract][Full Text] [Related]
4. A selective inhibitor of thromboxane synthetase activity of rabbit heart tissue: a pyridazinic derivative.
Pham Huu Chanh ; Lasserre B; Pham Huu Chanh A; Palhares de Miranda AL; Tronche P; Couquelet J; Rubat C
Prostaglandins Leukot Essent Fatty Acids; 1988 Aug; 33(2):143-7. PubMed ID: 3140251
[TBL] [Abstract][Full Text] [Related]
5. On the bioisosteric potential of diazines: diazine analogues of the combined thromboxane A2 receptor antagonist and synthetase inhibitor Ridogrel.
Heinisch G; Holzer W; Kunz F; Langer T; Lukavsky P; Pechlaner C; Weissenberger H
J Med Chem; 1996 Sep; 39(20):4058-64. PubMed ID: 8831771
[TBL] [Abstract][Full Text] [Related]
6. Enhanced prostacyclin biosynthesis and decreased thromboxane formation by 3-dimethylamino 5-(2',6'-dichlorobenzylidene) 6-methyl (4H)-pyridazine (PC 89).
Pham HC; Lasserre B; Tronche P; Couquelet J; Dossou-Gbete V; Palhares de Miranda AL
Prostaglandins Leukot Med; 1985 Jul; 19(1):37-49. PubMed ID: 3929276
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of [[(benzenesulfonamido)alkyl]phenyl]alkanoic acid derivatives containing pyridyl or imidazolyl groups and their thromboxane A2 receptor antagonistic and thromboxane A2 synthase inhibitory activities.
Sakurai S; Ogawa N; Suzuki T; Kato K; Ohashi T; Yasuda S; Kato H
Chem Pharm Bull (Tokyo); 1996 Aug; 44(8):1510-20. PubMed ID: 8795270
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
[TBL] [Abstract][Full Text] [Related]
9. Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 1. (+/-)-(3-pyridinylbicycloheptyl)alkanoic acids.
Bhagwat SS; Gude C; Cohen DS; Lee W; Furness P; Clarke FH
J Med Chem; 1991 Jun; 34(6):1790-7. PubMed ID: 1829485
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
Vezza R; Mezzasoma AM; Venditti G; Gresele P
Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439
[TBL] [Abstract][Full Text] [Related]
11. The in vitro effects of nicotine and cotinine on prostacyclin and thromboxane biosynthesis.
Chahine R; Calderone A; Navarro-Delmasure C
Prostaglandins Leukot Essent Fatty Acids; 1990 Aug; 40(4):261-6. PubMed ID: 2274564
[TBL] [Abstract][Full Text] [Related]
12. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets.
Chang TS; Kim HM; Lee KS; Khil LY; Mar WC; Ryu CK; Moon CK
Biochem Pharmacol; 1997 Jul; 54(2):259-68. PubMed ID: 9271330
[TBL] [Abstract][Full Text] [Related]
13. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets.
de Chaffoy de Courcelles D; De Clerck F
Eur J Pharmacol; 1990 Mar; 188(2-3):161-9. PubMed ID: 2318257
[TBL] [Abstract][Full Text] [Related]
14. Aminopyridazine derivatives and TXA2-PGI2 balance.
Chanh PH; Lasserre B; Kaiser R; Couquelet J; Coudert P; Rubat C
Prostaglandins Leukot Essent Fatty Acids; 1990 Jun; 40(2):143-8. PubMed ID: 2117291
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis and pharmacological modulation of thromboxane in humans.
Patrono C
Circulation; 1990 Jan; 81(1 Suppl):I12-5; discussion I22-3. PubMed ID: 2136814
[TBL] [Abstract][Full Text] [Related]
16. Guanidine derivatives as combined thromboxane A2 receptor antagonists and synthase inhibitors.
Soyka R; Guth BD; Weisenberger HM; Luger P; Müller TH
J Med Chem; 1999 Apr; 42(7):1235-49. PubMed ID: 10197967
[TBL] [Abstract][Full Text] [Related]
17. The effects of dipyridamole on TXA2 formation by horse platelet microsomes.
Katano Y; Imai S
Prostaglandins Leukot Med; 1983 Feb; 10(2):179-85. PubMed ID: 6573686
[TBL] [Abstract][Full Text] [Related]
18. Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. V. Thienopyridazinone derivatives.
Yamaguchi M; Maruyama N; Koga T; Kamei K; Akima M; Kuroki T; Hamana M; Ohi N
Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):236-40. PubMed ID: 7728930
[TBL] [Abstract][Full Text] [Related]
19. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro.
De Clerck F; Beetens J; de Chaffoy de Courcelles D; Freyne E; Janssen PA
Thromb Haemost; 1989 Feb; 61(1):35-42. PubMed ID: 2546278
[TBL] [Abstract][Full Text] [Related]
20. Ridogrel inhibits systemic and renal formation of thromboxane A2 and antagonizes platelet thromboxane A2/prostaglandin endoperoxide receptors upon chronic administration to man.
Weber C; Beetens JR; Tegtmeier F; Van Rooy P; Vercammen E; Wouters L; De Clerck F
Thromb Haemost; 1992 Aug; 68(2):214-20. PubMed ID: 1412169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
